Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Publication Number 20180282413
US 20180282413 A1Patent NumberUS 10138299 B2
Application Number16006473
Filled DateJun 12, 2018
Priority DateMay 15, 2012
Publication DateOct 4, 2018
Original AssigneeBristol Myers Squibb
Current AssigneeBristol Myers Squibb
Inventor/ApplicantsJon M. WIGGINTON
John P. COGSWELL
Ashok K. GUPTA
Maria JURE-KUNKEL
Maria Jure-Kunkel
John P. Cogswell
Ashok K. Gupta
Stacie M. Goldberg
Xi-Tao Wang
Xi-Tao WANG
Stacie M. GOLDBERG
Jon M. Wigginton
John P. COGSWELL
Ashok K. GUPTA
Maria JURE-KUNKEL
Maria Jure-Kunkel
John P. Cogswell
Ashok K. Gupta
Stacie M. Goldberg
Xi-Tao Wang
Xi-Tao WANG
Stacie M. GOLDBERG
Jon M. Wigginton
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.